Sep 7, 2026, 15:35
Abdulaziz Hamoudi: The Multicenter Randomized PROTECT-EST Trial Reports Impressive Results for SAP
Abdulaziz Hamoudi, Business Development Manager at ENDOHUB group, shared a post on LinkedIn:
”Peptide-first for post-sphincterotomy bleeding?
The multicenter randomized PROTECT-EST trial reports impressive results for self-assembling peptide (SAP) in persistent post-sphincterotomy oozing:
- 92.3 percent immediate hemostasis vs 76.9 percent with balloon tamponade
- 7.7 percent required rescue therapy vs 23.1 percent
Promising evidence supporting a peptide-first strategy in therapeutic endoscopy.
Proud to support the advancement of PuraStat self-assembling peptide technology in our region.
Study.”
Stay updated with Hemostasis Today.
-
Oct 28, 2026, 11:55Natalia C. Badillo: Anticoagulation in AF – A Decision Beyond the Score
-
Oct 28, 2026, 08:40Simon Fletcher: The Hidden Burden of Non-Severe Haemophilia
-
Oct 28, 2026, 08:08Paul Agwu: A Low Platelet Count Is Not a Diagnosis – It Is a Clue
-
Oct 28, 2026, 07:54Ifeanyichukwu Ifechidere: When Normal Results Don’t Explain the Bleeding
-
Oct 28, 2026, 06:06Thirunavukkarasu Angappan: Anti-TFPI Antibodies and an Antithrombin-Lowering Drug
-
Oct 28, 2026, 05:52Reegan Burnell-Clarke: Pegcetacoplan and the Evolving Treatment Landscape of PNH
-
Oct 28, 2026, 03:50ZhiChao (David) Yang: MedicalBench Tests AI in Clinical Reasoning
-
Oct 28, 2026, 03:46Phillip Smith: Strengthening Partnerships and Connections in the Rare Disease and Hemophilia Communities
-
Oct 28, 2026, 03:42Ashley Bradley: Understanding Jalen Hurts’ Diagnosis: DVT and Venous Thromboembolism in Athletes